This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Agency for Science, Technology and Research. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Chien Tei Too: Innovator in Hepatitis B Research
Introduction
Chien Tei Too is a notable inventor based in Singapore, recognized for his contributions to medical research, particularly in the field of hepatitis B. His innovative work has led to the development of a specific antibody that has significant implications for the treatment and understanding of the hepatitis B virus.
Latest Patents
Chien Tei Too holds a patent for a "Hepatitis B virus specific antibody and uses thereof." This patent includes at least one isolated TCR-like antibody or fragment capable of specifically binding to at least one HBV-derived peptide. This advancement is crucial for the development of targeted therapies against hepatitis B.
Career Highlights
Throughout his career, Chien Tei Too has worked with prominent institutions such as the Agency for Science, Technology and Research and the National University of Singapore. His work in these organizations has allowed him to contribute significantly to scientific research and innovation.
Collaborations
Chien Tei Too has collaborated with esteemed colleagues, including Antonio Bertoletti and Sastry Konduru Seetharama. These partnerships have enhanced his research efforts and expanded the impact of his work in the scientific community.
Conclusion
Chien Tei Too's innovative contributions to hepatitis B research exemplify the importance of targeted medical advancements. His patent and collaborations highlight his commitment to improving health outcomes through scientific innovation.